Does LUMATEPERONE Cause Off label use? 280 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Off label use have been filed in association with LUMATEPERONE (CAPLYTA). This represents 5.6% of all adverse event reports for LUMATEPERONE.
280
Reports of Off label use with LUMATEPERONE
5.6%
of all LUMATEPERONE reports
3
Deaths
36
Hospitalizations
How Dangerous Is Off label use From LUMATEPERONE?
Of the 280 reports, 3 (1.1%) resulted in death, 36 (12.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUMATEPERONE. However, 280 reports have been filed with the FAERS database.
What Other Side Effects Does LUMATEPERONE Cause?
Dizziness (558)
Nausea (401)
Headache (358)
Somnolence (304)
Drug ineffective (241)
Mania (211)
Sedation (208)
Feeling abnormal (206)
Anxiety (183)
Insomnia (183)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LUMATEPERONE Alternatives Have Lower Off label use Risk?
LUMATEPERONE vs LUMIGAN
LUMATEPERONE vs LUPRON DEPOT
LUMATEPERONE vs LUPRON DEPOT-PED
LUMATEPERONE vs LURASIDONE
LUMATEPERONE vs LURBINECTEDIN